Blog Posts by Date: Feb 2020


Why Your Lab Needs a Strategy to Launch Next Generation Sequencing

The Next Generation Sequencing market is growing at a rapid rate. Fortune Business Insights said the market was at $6.3 billion in 2018 and will surpass $31 billion by 2026, with a third of this market from NGS services. Contributing factors to this growth include drug discovery applications, diagnostic tests based on sequencing, and a rapid pace...

Read



The Importance of Lab-Specific Revenue Cycle Management for Hospital Labs

As a laboratory leader, you understand the value and impact of the patient care data you generate for hospital and community patients. On the business side of things, however, you aren’t always provided with the appropriate tools and visibility to position the lab to also be a profitable business entity. The time is now to challenge your...

Read



Outreach Labs Brace for Forthcoming Transparency Regulations

The Centers for Medicare and Medicaid Services’ (CMS) new hospital price transparency regulations will go into effect on January 1, 2021. Outreach labs are anticipating new challenges as a result of the rules.According to Adam Bonislawski’s article in 360DX, “Labs Brace for Potential Plusses, Minuses of Price Transparency Regulations,” the new...

Read



Recapping the NILA Lab Leaders Forum and Mid-Winter Meeting

Last weekend’s NILA conference covered a number of items currently impacting laboratories across the country. Several topics, in particular, saw repeated discussions and, in some cases, vigorous debate from the audience. Here are the hottest topics and key takeaways from the NILA meeting:Prior Authorization’s Pinch This was potentially one of the...

Read



The Growing Importance of Revenue Integrity in Hospital Outreach

Revenue integrity continues to be a hot topic in healthcare, even as its exact definition is still being hashed out. Broadly, revenue integrity focuses on reducing compliance risk while ensuring optimal reimbursement. The National Association of Healthcare Revenue Integrity (NAHRI) dryly states the goal of RI is “to prevent recurrence of issues...

Read



XIFIN RPM 11: Gain Unmatched Insights and Automation to Improve Claim Accuracy and Reimbursement

Diagnostic laboratory and independent device testing facility (IDTF) leaders face increasing volumes, more rigorous payor requirements, and changing reporting requirements. Diagnostic providers are actively seeking to maximize reimbursements and reduce costs. To help meet these demands, XIFIN has introduced the latest version of its an award-...

Read



Still Using Spreadsheets to Manage Your Lab Business? There Is a Better Way – Practical AI and Advanced Analytics

Laboratories, pathology practices, molecular diagnostic providers, and hospital outreach programs, as well as remote patient monitoring device companies, process millions of claims worth billions of dollars each year. Yet many diagnostic providers are still using spreadsheets, or legacy data management tools to do their financial or operational...

Read